======= DNAJC2 ======= == Gene Information == * **Official Symbol**: DNAJC2 * **Official Name**: DnaJ heat shock protein family (Hsp40) member C2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27000|27000]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99543|Q99543]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DNAJC2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DNAJC2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605502|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts both as a chaperone in the cytosol and as a chromatin regulator in the nucleus. When cytosolic, acts as a molecular chaperone: component of the ribosome-associated complex (RAC), a complex involved in folding or maintaining nascent polypeptides in a folding-competent state. In the RAC complex, stimulates the ATPase activity of the ribosome-associated pool of Hsp70-type chaperones HSPA14 that bind to the nascent polypeptide chain. When nuclear, mediates the switching from polycomb- repressed genes to an active state: specifically recruited at histone H2A ubiquitinated at 'Lys-119' (H2AK119ub), and promotes the displacement of the polycomb PRC1 complex from chromatin, thereby facilitating transcription activation. Specifically binds DNA sequence 5'-GTCAAGC-3'. {ECO:0000269|PubMed:15802566, ECO:0000269|PubMed:16002468, ECO:0000269|PubMed:21179169}. |Myb DNA-binding| |DnaJ| |de novo cotranslational protein folding| |ubiquitin modification-dependent histone binding| |negative regulation of DNA biosynthetic process| |de novo protein folding| |Hsp70 protein binding| |regulation of cellular response to heat| |regulation of DNA biosynthetic process| |negative regulation of DNA metabolic process| |histone binding| |DNA replication| |protein folding| |nuclear membrane| |regulation of DNA metabolic process| |chromatin binding| |chromatin organization| |regulation of cellular response to stress| |chromosome organization| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.71| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.73| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|1.76| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|1.77| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.96| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.06| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|2.06| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|2.12| |[[:results:exp70|INK128 0.2μM R02 exp70]]|2.2| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|2.24| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.55| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|2.76| |[[:results:exp504|MK2206 4μM R08 exp504]]|3.5| ^Gene^Correlation^ |[[:human genes:h:hspa14|HSPA14]]|0.598| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1351 * **Expression level (log2 read counts)**: 6.79 {{:chemogenomics:nalm6 dist.png?nolink |}}